Royalty Pharma plc
RPRX· Nasdaq
Royalty Pharma plc
- Last sale
- Oct 1, 2026 · -1.24%
- Market cap
- $33.14B
- 575M shares
- Filings
- 631
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,378,193,000 | reported | |
| FY 2024 | 2024-12-31 | $2,263,576,000 | reported | |
| FY 2023 | 2023-12-31 | $2,354,554,000 | reported | |
| FY 2022 | 2022-12-31 | $2,237,215,000 | reported | |
| FY 2021 | 2021-12-31 | $2,289,463,000 | reported | |
| FY 2020 | 2020-12-31 | $2,122,353,000 | reported | |
| FY 2019 | 2019-12-31 | $1,814,254,000 | reported | |
| FY 2018 | 2018-12-31 | $1,794,894,000 | reported |
Royalty Pharma plc · CIK 1802768 · Engraved from SEC EDGAR
